Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TCF4 | P15884 | 5/20 | 0.71 |
| ▸ | CTNNB1 | P35222 | 5/20 | 0.71 |
| ▸ | CDH1 | P12830 | 1/20 | 0.71 |
| ▸ | APC | P25054 | 1/20 | 0.71 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 3/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.33 |
| ▸ | SMAD3 | P84022 | 3/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cercosporin SCHEMBL6305985 | 1.00 | TCF4 (0.71) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL15185706 | 1.00 | TCF4 (0.71) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL498747 | 1.00 | TCF4 (0.71) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL28102616 | 0.99 | TCF4 (0.70) | TCF4CTNNB1CDH1APCTCF7L2 | |
| Cercosporin SCHEMBL21175561 | 0.94 | TCF4 (0.65) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL22930428 | 0.94 | TCF4 (0.64) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL29369377 | 0.83 | CTNNB1 (1.00) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL13121634 | 0.81 | CTNNB1 (0.49) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL8476647 | 0.71 | TCF4 (0.42) | TCF4CTNNB1CDH1APCTCF7L2 | |
| SCHEMBL29711267 | 0.66 | CTNNB1 (0.68) | TCF4CTNNB1CDH1APCTCF7L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4007582-B1 | ANTIBIOTICS IN COMBINATION WITH PHOTODYNAMIC THERAPY FOR USE IN A METHOD OF ENHANCING THE ANTIMICROBIAL ACTION OF SYSTEMICALLY ADMINISTERED ANTIBIOTICS | KOITE HEALTH OY (FI) | 2026-05-20 | — | — | EP | claimed |
| EP-4255560-B1 | KIT FOR TREATMENT OF PATIENTS HAVING DRY MOUTH SYNDROME | KOITE HEALTH OY (FI) | 2026-04-22 | — | — | EP | claimed |
| EP-4499596-A1 | PHOTOCHEMICAL PROCESS FOR PRODUCING ALCOHOLS | Fachhochschule Salzburg GmbH (AT) | 2025-02-05 | — | — | EP | claimed |
| WO-2023180559-A1 | PHOTOCHEMICAL PROCESS FOR PRODUCING ALCOHOLS | FACHHOCHSCHULE SALZBURG GMBH (AT) | 2023-09-28 | — | — | WO | claimed |
| EP-3784240-B1 | WNT6 AS GLIOBLASTOMA ONCOGENIC BIOMARKER, AND USES OF INHIBITORS THEREOF FOR TREATING WNT6-OVEREXPRESSING GLIOBLASTOMA | UNIV DO MINHO (PT) | 2023-09-20 | — | — | EP | claimed |
| US-12606649-B2 | Process for preparation of polyisobutene derivatives | BASF SE (DE) | 2026-04-21 | — | — | US | disclosed |
| EP-4499596-A1 | PHOTOCHEMICAL PROCESS FOR PRODUCING ALCOHOLS | Fachhochschule Salzburg GmbH (AT) | 2025-02-05 | — | — | EP | disclosed |
| US-20230406968-A1 | PROCESS FOR PREPARATION OF POLYISOBUTENE DERIVATIVES | BASF SE (DE) | 2023-12-21 | — | — | US | disclosed |
| WO-2023180559-A1 | PHOTOCHEMICAL PROCESS FOR PRODUCING ALCOHOLS | FACHHOCHSCHULE SALZBURG GMBH (AT) | 2023-09-28 | — | — | WO | disclosed |
| EP-4247860-A1 | PROCESS FOR PREPARATION OF POLYISOBUTENE DERIVATIVES | BASF SE (DE) | 2023-09-27 | — | — | EP | disclosed |
| WO-2022106263-A1 | PROCESS FOR PREPARATION OF POLYISOBUTENE DERIVATIVES | BASF SE (DE) | 2022-05-27 | — | — | WO | disclosed |
| EP-4001321-A1 | PROCESS FOR PREPARATION OF POLYISOBUTENE DERIVATIVES | BASF SE (DE) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606649-B2 | Process for preparation of polyisobutene derivatives | TCP1, POLD1, VAPA | TCF4 2592/4885CTNNB1 48/4885CDH1 1115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.